{"nct_id":"NCT00430781","title":"Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer","status":"COMPLETED","status_verified_date":"2015-04","start_date":"2006-11","start_date_type":null,"primary_completion_date":"2008-07","primary_completion_date_type":"ACTUAL","completion_date":"2011-07","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}